Binding and displacement of vascular endothelial growth factor (VEGF) by thrombospondin: effect on human microvascular endothelial cell proliferation and angiogenesis.

作者: Kalpna Gupta , Pankaj Gupta , Robert Wild , Sundaram Ramakrishnan , Robert P. Hebbel

DOI: 10.1023/A:1009018702832

关键词: Molecular biologyVascular endothelial growth factorHeparan sulfateCell growthTube formationBiologyBinding domainEndothelial stem cellThrombospondinImmunologyAngiogenesis

摘要: Vascular endothelial growth factor (VEGF) is a specific angiogenic factor, and thrombospondin (TSP), potent inhibitor of angiogenesis. To better understand the role TSP as an anti-angiogenic agent, we have identified its domains that participate in activity examined mechanism inhibitory effect on VEGF(165) induced Exogenously added inhibited angiogenesis (proliferation tube formation human dermal microvascular cells [HDMEC] neovascular outgrowth from arterial rings). Although both are heparin binding proteins, had higher affinity for (125)I-heparin than (K(d1) 4 nM K(d2) 14 TSP; K(d) 91 VEGF(165)). displaced 36% (125)I-VEGF(165) HDMEC this was comparable to 27% reduction upon cleavage cell surface heparan sulfate (HS). About 35% mitogenic attributable region. These results indicate proportion by via competition HS. Further, bound directly saturable, concentration dependent manner, modulated binding. The mAbs domain type 1 3 repeats TSP, also blocked proliferation. We conclude (i) localized (ii) inhibits at least two separate mechanisms, (a) displacement HS (b) direct VEGF(165).

参考文章(54)
Folkman J, The role of angiogenesis in tumor growth. Seminars in Cancer Biology. ,vol. 3, pp. 65- 71 ,(1992)
Richard Paul Tucker, Jack Lawler, Josephine C. Adams, The Thrombospondin Gene Family ,(1995)
S. Tessler, P. Rockwell, D. Hicklin, T. Cohen, B.Z. Levi, L. Witte, I.R. Lemischka, G. Neufeld, Heparin modulates the interaction of VEGF165 with soluble and cell associated flk-1 receptors. Journal of Biological Chemistry. ,vol. 269, pp. 12456- 12461 ,(1994) , 10.1016/S0021-9258(18)99896-0
William A. Frazier, Vivian S. Zabrenetzky, Patricia S. Steeg, David D. Roberts, Kenneth VanHoutte, Debra L. Weinstat-Saslow, Transfection of Thrombospondin 1 Complementary DNA into a Human Breast Carcinoma Cell Line Reduces Primary Tumor Growth, Metastatic Potential, and Angiogenesis Cancer Research. ,vol. 54, pp. 6504- 6511 ,(1994)
V M Dixit, W A Frazier, S A Santoro, V Ginsburg, D D Roberts, D M Haverstick, The platelet glycoprotein thrombospondin binds specifically to sulfated glycolipids. Journal of Biological Chemistry. ,vol. 260, pp. 9405- 9411 ,(1985) , 10.1016/S0021-9258(17)39381-X
O Aharonov, B W Griffin, D BenEzra, G Maftzir, Thrombospondin and in vivo angiogenesis induced by basic fibroblast growth factor or lipopolysaccharide. Investigative Ophthalmology & Visual Science. ,vol. 34, pp. 3601- 3608 ,(1993)
H Gitay-Goren, S Soker, I Vlodavsky, G Neufeld, The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules. Journal of Biological Chemistry. ,vol. 267, pp. 6093- 6098 ,(1992) , 10.1016/S0021-9258(18)42666-X
David D. Roberts, Regulation of tumor growth and metastasis by thrombospondin-1. The FASEB Journal. ,vol. 10, pp. 1183- 1191 ,(1996) , 10.1096/FASEBJ.10.10.8751720
K.A. Houck, D.W. Leung, A.M. Rowland, J Winer, N Ferrara, Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. Journal of Biological Chemistry. ,vol. 267, pp. 26031- 26037 ,(1992) , 10.1016/S0021-9258(18)35712-0
SS Tolsma, OV Volpert, DJ Good, WA Frazier, PJ Polverini, N Bouck, Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity Journal of Cell Biology. ,vol. 122, pp. 497- 511 ,(1993) , 10.1083/JCB.122.2.497